1 / 7

Immunohistochemistry Market worth 2.12 Billion USD by 2021

The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.

ritikatyagi97
Download Presentation

Immunohistochemistry Market worth 2.12 Billion USD by 2021

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MarketsandMarkets Presents Immunohistochemistry Market Insights on Scope and Growing Demands 2021 https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html

  2. ➢ [225 Pages Report] The immunohistochemistry market is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. ➢ Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected opportunities for players in the Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current immunohistochemistry market. https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html the IVD industry, and increasing to offer significant growth market. immunohistochemistry

  3. Early buyers will receive 10% customization on Reports. https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html

  4. ➢ Immunohistochemistry market is categorized into two application segments, namely, diagnostics immunohistochemistry market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases. In 2015, the diagnostics segment accounted for the largest share of the global immunohistochemistry market. The large share of this segment is attributed to growing prevalence of cancer, and wide application of immunohistochemistry in the diagnosis of cancers, infectious diseases, cardiovascular diseases, and other diseases. ➢ North America dominates the global immunohistochemistry market, and this trend is expected to continue during the forecast period. The large share of North America can be attributed to the fact that the majority of big players operating in the immunohistochemistry market are located in this region. In addition, the increasing geriatric population and rising incidence of chronic diseases like cancer, infectious diseases, and cardiovascular disease in this region are expected to boost the market for diagnostics. https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html and drug testing. The global

  5. ➢ The major players in the immunohistochemistry market are F. Hoffmann- La Roche AG (Switzerland), Danaher Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.). ➢ To speak to our analyst for a discussion on the above findings, click Speak to Analyst Corporation (U.S.), Agilent https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html

  6. About MarketsandMarkets MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html

  7. Contact Us Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/ Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets https://www.marketsandmarkets.com/Market- Reports/immunohistochemistry-market-121632939.html

More Related